CompanyGraph
CVS Health Corporation
CVS · NYSE Arca · United States
Sells health insurance through Aetna, then routes members' prescriptions to CVS-owned pharmacies, collecting money at both steps.
CVS Health enrolls people in Aetna health insurance plans, processes their prescription claims through its CVS Caremark benefits management system, and then routes those prescriptions to CVS-owned pharmacy locations — capturing the insurance premium and the dispensing margin inside one company rather than paying either out to a separate insurer or a competing pharmacy. Because CVS holds both the Aetna insurance licenses and the pharmacy licenses across more than 9,600 retail locations within the same corporate structure, it can write formularies that steer covered drugs toward its own stores in a way that a company owning only one of those two pieces could not. The routing advantage only holds, however, where CVS already has enough stores — in thinner markets, state regulators enforcing network adequacy rules require Aetna to accept competing pharmacies on equal terms, which breaks the internal loop in those geographies. If federal regulators or state legislatures required CVS to separate the insurance and pharmacy operations entirely, the formulary would lose its power to direct claims inward, and both the premium revenue and the dispensing margin would revert to transactions between independent companies.
How does this company make money?
CVS collects monthly or annual premiums from employer groups and Medicare Advantage members through Aetna. When those members fill prescriptions at CVS retail stores, CVS earns dispensing fees and collects copayments. CVS Caremark charges employers and health plans administrative fees to manage their drug benefits and receives rebate payments from drug manufacturers in exchange for placing their drugs in preferred positions on the formulary. CVS Specialty earns higher margins by distributing expensive specialty drugs directly to patients with complex conditions.
What makes this company hard to replace?
Aetna members whose employer switches insurance carriers would have to transfer all their prescriptions to a new pharmacy network, which is a disruption most people want to avoid. Employers that use CVS Caremark as their pharmacy benefit manager would need to rebuild prior authorization systems — the approval workflows that determine which drugs get covered — from scratch if they moved to a competing manager like Express Scripts or OptumRx. Both of those friction points make switching costly enough that most customers stay.
What limits this company?
State insurance commissioners must approve each Aetna formulary before it can steer members toward CVS pharmacies, and they will only approve it if CVS has enough pharmacy locations nearby to meet coverage requirements. In any city or region where CVS does not have enough stores, regulators would force Aetna to accept other pharmacies on equal terms, and the internal routing advantage disappears in those markets.
What does this company depend on?
CVS cannot operate without DEA pharmacy licenses for each of its 9,600+ retail locations, Aetna's state insurance licenses in every market where it sells health plans, NCPDP electronic infrastructure that routes prescriptions from doctors to CVS pharmacies, direct distribution agreements with specialty drug manufacturers for CVS Specialty, and CMS approvals to participate in Medicare Part D and Medicaid managed care.
Who depends on this company?
Aetna health plan members rely on CVS pharmacy networks to fill prescriptions, and if those networks became unavailable their access to medication would be disrupted. Long-term care facilities served by Omnicare depend on CVS-controlled pharmaceutical supply chains to deliver residents' medications — without that, distribution would halt. Employers who use the combined CVS Caremark and CVS Pharmacy arrangement would face higher pharmacy benefit costs if forced to piece together separate arrangements with outside pharmacy benefit managers.
How does this company scale?
Opening additional CVS Pharmacy locations and enrolling more Aetna members is relatively straightforward — it requires standard retail leases and insurance license applications in new markets. What does not scale as easily is the closed-loop routing advantage: it only works where CVS already has enough stores. In markets where CVS retail density is thin, regulators require Aetna to include competing pharmacies, which breaks the internal routing benefit in those areas.
What external forces can significantly affect this company?
CMS regulations require CVS to disclose how rebates flow between its Caremark benefit management operation and its pharmacy locations, which could reduce its pricing flexibility. California SB 17 restricts health insurers from owning pharmacies, and similar laws in other states could force structural changes. The Federal Trade Commission has been actively scrutinizing vertical mergers between health insurers and pharmacy companies since the 2018 Aetna acquisition, and a future enforcement action could require CVS to break apart operations it currently runs as one unit.
Where is this company structurally vulnerable?
If the Federal Trade Commission ordered CVS to sell off either its Aetna insurance business or its CVS Pharmacy retail network, or if states passed laws like California SB 17 banning health insurers from owning pharmacies, the formulary would lose its ability to send claims to CVS-owned locations. The insurance premiums and the pharmacy dispensing margins would then flow to separate, unrelated companies, and CVS would be left competing as either a standalone insurer or a standalone pharmacy benefit manager against rivals like UnitedHealth-OptumRx that already have their own integrated structures.